Advertisement

Ads Placeholder
Loading...

Supriya Lifescience Limited

SUPRIYA.BOBSE
Healthcare
Biotechnology
612.10
9.45(1.57%)
Indian Market opens in 34h 48m

Supriya Lifescience Limited (SUPRIYA.BO) Stock Overview

Explore Supriya Lifescience Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap49.3B
P/E Ratio26.60
EPS (TTM)$23.01
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$749.57
3 Months$788.02
1 Year Target$813.68

SUPRIYA.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Supriya Lifescience Limited (SUPRIYA.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $813.68.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.60 and a market capitalization of 49.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.57%
5-Day Change
2.88%
1-Month Change
-1.17%
3-Month Change
-18.50%
6-Month Change
-16.19%
Year-to-Date (YTD) Change
-17.15%
1-Year Change
-22.94%
3-Year Change
208.67%
5-Year Change
56.81%
All-Time (Max) Change
56.81%

Contact Information

91 22 4033 2727
207/208 Udyog Bhavan, Mumbai, NaN, 400063

Company Facts

4,480 Employees
IPO DateDec 28, 2021
CountryIN
Actively Trading

Frequently Asked Questions